This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 22.88% and 7.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Centene Beat Q1 Earnings Estimates on Growing Premiums?
by Zacks Equity Research
CNC's first-quarter results are likely to benefit from higher commercial marketplace memberships.
Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exploring Analyst Estimates for Centene (CNC) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Centene (CNC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Centene (CNC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will a Strong MA Business Aid Elevance Health's Q1 Earnings?
by Zacks Equity Research
ELV's Q1 results are expected to reap the benefits of higher premiums from growing Medicare Advantage membership and acquisitions pursued within the Carelon unit.
Should Invesco S&P 500 Pure Value ETF (RPV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RPV
Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RPV
Centene Extends SilverSummit's Presence to the Edges of Nevada
by Zacks Equity Research
CNC's subsidiary, SilverSummit, secures a five-year Nevada Medicaid contract, reinforcing its foothold in managed care in rural and frontier areas.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks.com featured highlights Cleveland-Cliff, Peabody, CVR Energy, Delek US and Centene
by Zacks Equity Research
Cleveland-Cliff, Peabody, CVR Energy, Delek US and Centene have been highlighted in this Screen of The Week article.
5 Broker-Loved Stocks to Watch Amid Tariff-Induced Market Bloodbath
by Maharathi Basu
Investors would do well to monitor broker-friendly stocks like CLF, BTU, CVI, DK and CNC for high returns.
The Zacks Analyst Blog Highlights Lamb Weston, Centene, The Kroger, First Solar and American Water Works
by Zacks Equity Research
Lamb Weston, Centene, The Kroger, First Solar and American Water Works are included in this Analyst Blog.
5 S&P 500 Stocks Unscathed by the Market Mayhem
by Sweta Killa
The S&P 500 shed about $2.4 trillion in market cap in yesterday's trading session. Still, stocks like LW, CNC, KR, FSLR and AWK showed strength.
Strength Seen in Centene (CNC): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene
by Zacks Equity Research
UnitedHealth, Humana and Centene are part of the Zacks Industry Outlook article.
3 HMO Stocks to Watch Amid Nurse Shortages, High Tech Costs
by Debasmita Chatterjee
The Medical-HMO industry rides on steady premium flows resulting from a growing customer base and contract wins. However, industry headwinds like elevated technology costs and workforce shortages remain concerns. UNH, HUM and CNC are likely to navigate industry storms.
Humana Gains on Strong Membership Base and Sound Cash Reserves
by Zacks Equity Research
HUM benefits from a cost-effective health plan suite, continued expansion endeavors and a strong 2025 business outlook.
Centene & HMHB Hawaii Expand Partnership for Maternal Care
by Zacks Equity Research
CNC's Ohana Health Plan and HMHB Hawaii expand maternal care, enhancing support for mothers and babies through strategic investment and community partnerships.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
5 Broker-Preferred Stocks to Monitor Amid Tariff-Induced Volatility
by Maharathi Basu
Investors should keep an eye on stocks like Air Canada, Enerflex, AutoNation, Centene and CVS Health for high returns.
The Joint (JYNT) Stock Jumps 10.0%: Will It Continue to Soar?
by Zacks Equity Research
The Joint (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Centene's Meridian Unit Secures a D-SNP Contract in Illinois
by Zacks Equity Research
CNC's Meridian Health Plan wins a D-SNP contract in Illinois, expanding enhanced managed care for Medicare-Medicaid-eligible individuals. The deal is likely to boost Centene's foothold and membership base in the state.